1st Quarter - Report
FEROX STRATEGIES for ALEXION PHARMACEUTICALS, INC.
Firm
Income
$60,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to rare disease pharmaceuticals, ORPHAN Cures, and Pediatric Priority Review Voucher
| Lobbyist | Covered position, as disclosed |
|---|---|
| CRISTINA ANTELO | — |
| DEBRA DIXON | — |
| ZACHARY BENJAMIN FRIEND New | — |
| MICHAEL TAGGART | — |
| MARK WILLIAMS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.